ibogaine - CISMeF

Preferred Label : ibogaine;

MeSH definition : One of several indole alkaloids extracted from Tabernanthe iboga, Baill. It has a complex pharmacological profile, and interacts with multiple systems of neurotransmission. Ibogaine has psychoactive properties and appears to modulate tolerance to opiates.;

MeSH synonym : 12 methoxyibogamine; 12-methoxyibogamine;

MeSH hyponym : NIH-10567; endabuse; NIH 10567; NIH10567;

MeSH CAS label : ibogamine, 12-methoxy-;

MeSH Related Number : 83-74-9 (Ibogaine);

Registry Number MeSH : 83-74-9;

Wikipedia link : https://en.wikipedia.org/wiki/Ibogaine;

Codes EINECS : 201-498-4;

Is substance : O;

UNII : 3S814I130U;

InChIKey : HSIBGVUMFOSJPD-CFDPKNGZSA-N;

Details

Origin ID

D007050;

UMLS CUI

C0020737;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
CISMeF manual mappings
- ibogaine [Substance BNPC]
Pharmacological action(s)
- excitatory amino acid antagonists [MeSH Descriptor]
- hallucinogens [MeSH Descriptor]
- neurotransmitter agents [MeSH Descriptor]
Record concept(s)
- NIH-10567 [MeSH concept]
- endabuse [MeSH concept]
- ibogaine [MeSH concept]
Related MeSH Supplementary Concept(s)
- 18-hydroxycoronaridine [MeSH Supplementary Concept]
- 18-methoxycoronaridine [MeSH Supplementary Concept]
- 2-methoxyethyl 18-methoxycoronaridinate [MeSH Supplementary Concept]
- 20-desethyl-20-hydroxymethyl-11-demethoxyibogaine [MeSH Supplementary Concept]
- 3'-hydroxyvoacamine [MeSH Supplementary Concept]
- coronardine [MeSH Supplementary Concept]
- heyneanine hydroxy-indolenine [MeSH Supplementary Concept]
- noribogaine [MeSH Supplementary Concept]
- tabernanthine [MeSH Supplementary Concept]
- technetium 99m tricarbonyl ibogaine [MeSH Supplementary Concept]
- voacamine [MeSH Supplementary Concept]
- voacangine [MeSH Supplementary Concept]
- voacristine [MeSH Supplementary Concept]
Semantic type(s)
- Biologically Active Substance [UMLS semantic type]
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- ibogaine [Substance BNPC]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients